Skip to main content
. Author manuscript; available in PMC: 2021 Aug 10.
Published in final edited form as: Am J Nephrol. 2020 Aug 10;51(9):715–725. doi: 10.1159/000509451

Fig. 2. Pre-end-stage renal disease (ESRD) frequency of opiate prescription and post-ESRD mortality risk in the one-year (Panel A), two-year (Panel B), and five-year (Panel C) prelude cohorts (ref: no analgesic use).

Fig. 2.